FI20011542A0 - Urosognaasigeenin monistuman käyttö - Google Patents
Urosognaasigeenin monistuman käyttöInfo
- Publication number
- FI20011542A0 FI20011542A0 FI20011542A FI20011542A FI20011542A0 FI 20011542 A0 FI20011542 A0 FI 20011542A0 FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A FI20011542 A FI 20011542A FI 20011542 A0 FI20011542 A0 FI 20011542A0
- Authority
- FI
- Finland
- Prior art keywords
- carcinomas
- amplification
- urogenase
- gene
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
| PCT/FI2002/000636 WO2003006690A1 (en) | 2001-07-13 | 2002-07-15 | Use of urokinase gene amplification as a marker |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI20011542A0 true FI20011542A0 (fi) | 2001-07-13 |
| FI20011542A7 FI20011542A7 (fi) | 2003-01-14 |
| FI20011542L FI20011542L (fi) | 2003-01-14 |
Family
ID=8561659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI20011542A FI20011542L (fi) | 2001-07-13 | 2001-07-13 | Urosognaasigeenin monistuman käyttö |
Country Status (2)
| Country | Link |
|---|---|
| FI (1) | FI20011542L (fi) |
| WO (1) | WO2003006690A1 (fi) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2886946B1 (fr) * | 2005-06-09 | 2007-08-10 | Biomerieux Sa | Procede pour le diagnoctic/pronostic du cancer du sein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5422090A (en) * | 1984-08-13 | 1995-06-06 | Biotechnology Australia, Pty., Ltd. | Human PAI-2 |
| AU733222B2 (en) * | 1997-11-25 | 2001-05-10 | Genentech Inc. | Fibroblast growth factor-19 |
-
2001
- 2001-07-13 FI FI20011542A patent/FI20011542L/fi unknown
-
2002
- 2002-07-15 WO PCT/FI2002/000636 patent/WO2003006690A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003006690A1 (en) | 2003-01-23 |
| FI20011542A7 (fi) | 2003-01-14 |
| FI20011542L (fi) | 2003-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3059322T3 (da) | Genekspressionsmarkører for brystcancerprognose | |
| IL182423A0 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
| MXPA03003281A (es) | Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos. | |
| WO2006012646A3 (en) | Amacr cancer markers | |
| WO2001070979A3 (en) | Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer | |
| ATE538215T1 (de) | Expressionsprofil von prostatakarzinom | |
| EP1893196A4 (en) | DIARYLHYDANTOIN CONNECTIONS | |
| DE69940436D1 (de) | Prostata stammzellantigen (psca) und dessen verwendungen | |
| DE60226271D1 (de) | Verfahren zum nachweis von prostatakrebs | |
| AU2002337657A1 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
| WO2003000012A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
| UA116188C2 (uk) | Інгібітори фосфатидилінозит-3-кінази і способи їх застосування | |
| AU2001229340A1 (en) | Genes compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
| DE69942827D1 (de) | Verwendung der epothilons zur behandlung der krebs | |
| WO2001042467A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
| EP2130926A3 (en) | Phage microarray profiling of the humoral response to disease | |
| WO2005053604A3 (en) | Antibodies specific for cancer associated antigen sm5-1 and uses thereof | |
| EP1377596A4 (en) | USE OF THE TTK FOR DIAGNOSTIC PURPOSES AND AS A THERAPEUTIC TARGET OF CANCER | |
| HUP0303649A2 (hu) | Mátrix-metalloproteináz-inhibitorok liposzómás célzása | |
| WO2004031402A3 (en) | Methylation profile of cancer | |
| WO2003044161A3 (en) | Gene amplification and overexpression in cancer | |
| FR2875601B1 (fr) | Vimentine phosphorylee comme marqueur de l'agressivite et/ou l'invasivite des tumeurs | |
| EP1451552A4 (en) | FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS | |
| TW200517122A (en) | Antibodies specific for cancer associated antigen SM5-1 and uses thereof | |
| FI20011542A0 (fi) | Urosognaasigeenin monistuman käyttö |